In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Humana Inc (NYSE: HUM) closed at $296.91 in the last session, up 0.91% from day before closing price of $294.23. In other words, the price has increased by $0.91 from its previous closing price. On the day, 1.16 million shares were traded. HUM stock price reached its highest trading level at $298.01 during the session, while it also had its lowest trading level at $288.7123.
Ratios:
We take a closer look at HUM’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on November 06, 2024, Upgraded its rating to Neutral and sets its target price to $308 from $247 previously.
Bernstein Upgraded its Mkt Perform to Outperform on October 08, 2024, while the target price for the stock was maintained at $308.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 31 ’24 when Huval Timothy S. sold 3,703 shares for $256.26 per share. The transaction valued at 948,925 led to the insider holds 8,181 shares of the business.
Huval Timothy S. bought 3,703 shares of HUM for $938,433 on Dec 31 ’24. On Dec 06 ’24, another insider, William K. Fleming, who serves as the Officer of the company, bought 8,661 shares for $283.06 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 35751231488 and an Enterprise Value of 24716630016. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.29, and their Forward P/E ratio for the next fiscal year is 17.75. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.31 while its Price-to-Book (P/B) ratio in mrq is 2.04. Its current Enterprise Value per Revenue stands at 0.215 whereas that against EBITDA is 6.541.
Stock Price History:
The Beta on a monthly basis for HUM is 0.56, which has changed by -0.22340119 over the last 52 weeks, in comparison to a change of 0.21794415 over the same period for the S&P500. Over the past 52 weeks, HUM has reached a high of $406.46, while it has fallen to a 52-week low of $213.31. The 50-Day Moving Average of the stock is 7.35%, while the 200-Day Moving Average is calculated to be -6.32%.
Shares Statistics:
According to the various share statistics, HUM traded on average about 1.79M shares per day over the past 3-months and 1736530 shares per day over the past 10 days. A total of 120.41M shares are outstanding, with a floating share count of 120.14M. Insiders hold about 0.23% of the company’s shares, while institutions hold 95.52% stake in the company. Shares short for HUM as of 1736899200 were 5175421 with a Short Ratio of 2.89, compared to 1734048000 on 4451197. Therefore, it implies a Short% of Shares Outstanding of 5175421 and a Short% of Float of 4.3.
Dividends & Splits
The forward annual dividend rate for HUM is 3.54, which was 3.54 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.012031403The stock’s 5-year Average Dividend Yield is 0.73. The current Payout Ratio is 17.70% for HUM, which recently paid a dividend on 2024-12-31 with an ex-dividend date of 1735603200. Stock splits for the company last occurred on 1991-08-01 when the company split stock in a 3:2 ratio.
